Sen. Bill Cassidy (R-LA) said he supports the nomination of Dr. Erica Schwartz to lead the Centers for Disease Control and Prevention.
The endorsement comes as the agency seeks to rebuild its reputation following years of political volatility and public scrutiny over health guidelines. Support from key committee members is essential for the confirmation process on Capitol Hill.
During a hearing before the Senate Health, Education, Labor and Pensions Committee on July 15, 2026, Cassidy expressed confidence in the nominee's qualifications. He said he looks forward to working with Schwartz to protect the health of children and restore public trust in the CDC [1].
However, the path to this support was not entirely seamless. Reports indicate that Cassidy described some of Schwartz's answers during the hearing as "disappointing" [2]. This tension suggests a complex dynamic between the nominee's testimony and the senator's ultimate decision to back her candidacy.
This period of uncertainty lasted nearly a week before Cassidy announced his support [2]. The delay highlighted the scrutiny facing the nominee regarding her views on vaccines and public health mandates.
Despite those misgivings, Cassidy remained positive about the potential for a productive partnership. "I'm confident that she knows what she is doing," Cassidy said [1]. He emphasized that the primary goal remains the stability of the nation's leading public health agency.
Schwartz's confirmation remains a focal point for the Senate as the committee weighs her expertise against the specific concerns raised by legislators during the July 15 proceedings [3].
“"I'm confident that she knows what she is doing."”
The endorsement from Sen. Cassidy, a physician and influential member of the health committee, signals that the nominee has likely cleared a major hurdle for confirmation. While his critiques of her testimony reveal lingering concerns over her specific policy stances, the decision to prioritize agency stability and child health suggests a pragmatic approach to filling the CDC leadership vacancy.
